Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial
Clinical trial NCT07269509 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07269509
- Sponsor
- Renmin Hospital of Wuhan University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-12-31
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.